BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:29 PM
Sep 20, 2012
 |  BC Extra  |  Company News

Boehringer submits afatinib MAA for NSCLC

Boehringer Ingelheim GmbH (Ingelheim, German) submitted an MAA to EMA for oral afatinib to treat EGFR-mutation-positive non-small...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >